BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Krsnaa Diagnostics Ltd. Share Price

NSE
BSE

NSE : KRSNAA

BSE : 543328

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹582.00

High

₹594.05

Price Summary

Previous Close ₹587.50
Day's Range ₹582.00 - ₹594.05
Open ₹585.25
52 Week Range ₹515.00 - ₹894.40
Volume 21,518
Market Cap ₹0.00
Previous Close ₹588.40
Day's Range ₹582.05 - ₹594.45
Open ₹594.00
52 Week Range ₹502.20 - ₹891.80
Volume 852
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 126.42
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.47
Price/Earning (TTM) 23.81
TTM EPS (₹) 24.78
P/E Ratio 32.68
Book Value(₹) 2.04
PAT Margin (%) 10.82
Face Value (₹) 5.00
ROCE(%) 12.39
Trade Value ( ₹ in Lacs) 5.01
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.47
Price/Earning (TTM) 23.81
TTM EPS (₹) 24.78
P/E Ratio 32.68
Book Value(₹) 2.04
PAT Margin (%) 10.82
Face Value (₹) 5.00
ROCE(%) 12.39

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 1745.12 5900.19
Expenses N/A N/A
PBT 254.78 719.45
Operating profit 0.0 0.0
Net profit 194.15 585.62

Shareholding Pattern

Promoters (% Holding)

27.11%

Mutual funds (% Holding)

10.17%

Non-Institution (% Holding)

55.08%

FI/Banks/Insurance (% Holding)

2.67%

Government (% Holding)

0.00%

FII

3.91%

About Krsnaa Diagnostics Ltd.

Founded 2010
Managing Director Yash Mutha
NSE Symbol KRSNAA

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,37,662.69 1,816.00 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 1,75,692.42 6,650.75 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,43,908.69 4,293.00 3,101.60 - 3,101.60
Apollo Hospitals Enterprise Ltd. 1,11,261.29 7,760.00 6,677.50 - 6,677.50
Cipla Ltd. 1,07,826.86 1,330.00 1,165.70 - 1,165.70
Dr. Reddy's Laboratories Ltd. 1,07,499.64 1,271.60 1,129.40 - 1,129.40
Lupin Ltd. 1,07,489.16 2,344.50 1,836.80 - 1,836.80
Max Healthcare Institute Ltd. 98,438.74 1,003.05 903.00 - 903.00
Mankind Pharma Ltd. 93,323.97 2,329.00 1,909.70 - 1,909.70
Zydus Lifesciences Ltd. 90,727.09 919.85 835.50 - 835.50
no-content No Records Found

Latest News

Mar
17
2026
EQUITY Posted on Mar 17th 2026

Krsnaa Diagnostics submits newspaper advertisement

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Krsnaa Diagnostics has informed that it enclosed copies of notice given to the Members of the Company in accordance with the applicable provisions of the Companies Act, 2013, read with the Rules issued thereunder, and the Listing Regulations, informing them about the resolution proposed to be passed by Postal Ballot through e-voting process only and details thereof. The advertisements published today, March 17, 2026, in the newspapers: Financial Express, English newspaper and Loksatta, Marathi newspaper. This will also be hosted on Company’s website at www.krsnaadiagnostics.com/investors.

The above information is a part of company’s filings submitted to BSE.

Read More
Mar
16
2026
EQUITY Posted on Mar 16th 2026

Krsnaa Diagnostics submits notice of postal ballot

Krsnaa Diagnostics has informed that it enclosed intimation of Postal Ballot Notice for the re-appointment of Rajendra Khivraj Mutha as Whole-time Director of the Company designated as Executive Chairman.
The above information is a part of company’s filings submitted to BSE.
Read More
Feb
26
2026
EQUITY Posted on Feb 26th 2026

Krsnaa Diagnostics informs about analyst meet

Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Krsnaa Diagnostics has informed that the officials of the Company will be meeting Investors/Analysts (Participants) Omega Portfolio Advisors on February 27, 2026 at 10:00 Hrs. (IST) onwards in Pune (One-on-One). Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. 
The above information is a part of company’s filings submitted to BSE.
Read More
Feb
7
2026
EQUITY Posted on Feb 7th 2026

Krsnaa Diagnostics informs about newspaper advertisement

Pursuant to Regulation 47 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Krsnaa Diagnostics has informed that it enclosed copies of the newspaper advertisement pertaining to the Unaudited (Standalone and Consolidated) Financial Results for the quarter and nine months ended December 31, 2025. The advertisements are published on February 07, 2026 in the Newspapers: Financial Express, English newspaper and Loksatta, Marathi newspaper. This will also be hosted on the Company’s website at www.krsnaadiagnostics.com/investors.

The above information is a part of company’s filings submitted to BSE. 

Read More
Feb
6
2026
EQUITY Posted on Feb 6th 2026

Krsnaa Diagnostics informs about analyst meet outcome

Pursuant to Regulation 30 read with Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Krsnaa Diagnostics has enclosed the Audio Link for the earnings conference call of the Company, for the quarter and nine months ended December 31, 2025 conducted through digital means on Friday, February 06, 2026 at 12:30 Hrs. (IST) is available on the website of the Company under the following link: krsnaadiagnostics.com/investor-docs/2026/Earnings Calls Recordings/Earnings call recording for the quarter ended December 31%2C 2025.mp3
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Krsnaa Diagnostics Ltd. ?

The current share price of Krsnaa Diagnostics Ltd. is ₹587.50 as of 2026-05-05.

The market capitalisation of Krsnaa Diagnostics Ltd. is ₹1,914.21 as of 2026-05-04.

The 1-year return of Krsnaa Diagnostics Ltd. is -1.60% as of 2026-05-05.

The P/E ratio of Krsnaa Diagnostics Ltd. is 32.68 as of 2026-05-05.

The 52-week high and low of Krsnaa Diagnostics Ltd. are ₹894.40 and ₹515.00, respectively, as of 2026-05-05.

The dividend yield of Krsnaa Diagnostics Ltd. is 0.466% as of2026-05-04.

You can buy Krsnaa Diagnostics Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Krsnaa Diagnostics Ltd. is Yash Mutha.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Personal Loan
My Accounts
My Accounts
Explore
Explore